Janssen, Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc.  
   Our Company
   Innovation & Research
   Commitment - We Will
We Will
Healthcare Professionals
Initiatives
   Our Products
   Therapy Areas
   Our Giving
   Medical Education
   News Center
   Contact Us

We Will
At Janssen we've simplified our focus and amplified our commitment.

Now exclusively dedicated to the treatment of mental health.

We Will...

... Advance treatment
At our state-of-the-art research facilities, we're researching and developing compounds for a wide range of psychiatric disorders.

... Go beyond medication
Because we know that, with mental illness, successful treatment involves more than just medication, we've strengthened our partnerships with advocacy groups and increased our investment in a broad array of unique resources, tools, and services.

... Promote access to treatment
Janssen is working at the state and federal levels to ensure access to care and medicine for those affected by mental illness.

In addition, we're helping patients in financial need receive medications through our participation in a number of well-resourced prescription drug assistance programs, such as the Partnership for Prescription Assistance (PPA) Program and the Together Rx Access ™ Card.

We also offer assistance to ensure access to our medications through our Patient Assistance Program and CONSTANTAccess™ service.

Click here to find out more about our We Will Initiatives.

Click here to learn what we've heard from healthcare professionals.

Click here for a PDF version of our We Will brochure.